Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 278 clinical trials
None
A Study of ERAS-007 in Patients With Advanced Non-Small-Cell Lung Cancer

To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced non-small cell lung cancer (NSCLC

  • 0 views
  • 24 Sep, 2021
  • 4 locations
None
A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced GI malignancies. To

  • 0 views
  • 14 Oct, 2021
  • 1 location
None
Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma

radiotherapy. Sunitinib is a new drug that is active against cells with low oxygen levels. The combination of sunitinib and radiotherapy has shown promising results in other cancers. The purpose of

cancer
  • 12 views
  • 07 Nov, 2020
  • 1 location
None
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N

make the immune response more active and may improve the response of the immune system against cancer. Pembrolizumab is currently FDA approved for use in other malignancies. It has been used to treat

  • 0 views
  • 17 Jul, 2021
  • 1 location
None
A First in Human Study of BAY2701439 to Look at Safety How the Body Absorbs Distributes and Excretes the Drug and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein

, as well as other cancers that have HER2. Researchers want to find the best dose of BAY2701439 for patients and look at the way the body absorbs, distributes and excretes the drug. The study

  • 0 views
  • 08 Oct, 2021
  • 6 locations
None
The PET- Retroperitoneal Sarcoma Study

response. Functional imaging by PET scan is used in other tumour types to identify early response to treatment. PET imaging may provide a more meaningful assessment of RPS response to systemic therapy

  • 0 views
  • 18 Apr, 2021
  • 1 location
None
Dissecting the Heterogeneity of Oral Cancer Pain

Oral squamous cell carcinoma (SCC) produces a higher prevalence and more severe pain than all other cancers. Orofacial pain is one of the most common initial symptoms of oral cancer and often

  • 0 views
  • 04 Sep, 2021
  • 1 location
None
Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC

diagnosis at late stages. Surgical results in earlier stages are poor compared to other tumor types (about 40% of recurrence in stages I-II). Results of chemotherapy in advanced stages are also

metastasis
neutrophil count
vinorelbine
stage iv non-small cell lung cancer
secondary malignant neoplasm of liver
  • 3 views
  • 07 Nov, 2020
  • 1 location
None
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy

enrolled in the trial: Non-Small Cell Lung Cancer (NSCLC), Head and neck cancer, Melanoma, Bladder cancer, Other tumor types when Immuno-Oncology agent

  • 10 views
  • 26 Jan, 2021
  • 2 locations
None
Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly

In this research study, the investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may improve health care delivery. It is expected that about 12,000 people will take part in this research study, 11,550 of these patients, the vast majority, will be included …

  • 0 views
  • 26 Jan, 2021
  • 3 locations